MARKET

HTFL

HTFL

HEARTFLOW INC
NASDAQ
59.71
+3.91
+7.00%
Opening 14:38 11/11 EST
OPEN
56.61
PREV CLOSE
55.80
HIGH
60.66
LOW
56.61
VOLUME
1.26M
TURNOVER
--
52 WEEK HIGH
60.66
52 WEEK LOW
20.13
MARKET CAP
5.19B
P/E (TTM)
-32.7456
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HTFL last week (1102-1106)?
Weekly Report · 2d ago
HeartFlow (HTFL) Shares Just Dropped, So What Is Drawing Attention?
Simply Wall St · 11/03 06:18
Heartflow To Present DECIDE Registry Data Showing 34% Reduction In Major Cardiovascular Events With AI Plaque Analysis, At AHA Scientific Sessions 2026
Benzinga · 11/02 13:03
Weekly Report: what happened at HTFL last week (1026-1030)?
Weekly Report · 11/02 09:00
Heartflow announces P4 study of CT-guided PCI planning met primary endpoint
TipRanks · 11/01 19:05
Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 10/27 21:20
Weekly Report: what happened at HTFL last week (1019-1023)?
Weekly Report · 10/26 09:00
Elucid Bioimaging Says Co Is Aware Of A Lawsuit Filed By Heartflow, On October 22, 2026. Elucid Will Respond To And Defend Against The Claims In The Lawsuit Through The Appropriate Legal Channels
Benzinga · 10/23 18:22
More
About HTFL
Heartflow, Inc. is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). Its novel Heartflow Platform uses AI and advanced computational fluid dynamics to create a personalized 3D model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Heartflow RoadMap Analysis, Heartflow FFRCT Analysis, Heartflow Plaque Analysis and Heartflow PCI Navigator. Its Heartflow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. Heartflow RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review. Heartflow FFRCT Analysis calculates blood flow and pinpoints clinically significant CAD.

Webull offers Heartflow, Inc. stock information, including NASDAQ: HTFL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HTFL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HTFL stock methods without spending real money on the virtual paper trading platform.